Ruxolitinib cream shows rapid, significant repigmentation in NSV, aligning with phase 3 trial outcomes and suggesting first-line therapy potential, especially for facial involvement. The study's ...

Forbes contributors publish independent expert analyses and insights. Jamie Gold writes about wellness design and related housing topics. The Covid pandemic clarified the links between our homes and ...

If you or someone you know is in crisis, contact the 988 Suicide & Crisis Lifeline via call, text or chat. A new study finds that addiction to social media, mobile phones and video games is linked to ...

NICE, France — Visual acuity remains stable or continues to improve over 5 years in most patients treated with ranibizumab (Lucentis, Genentech) for neovascular age-related macular degeneration under ...

According to Novo Nordisk, this study was the first to compare these GLP-1 receptor agonists in a real-world setting. Findings from a real-world study evaluating cardiovascular disease-related ...

Forbes critique argues that Anthropic's March 2026 study on AI labor-market impacts is too narrow—relying solely on Claude usage data—and fails to accurately measure real economy-wide effects on jobs, ...

New research shows patients commonly take lower doses of nintedanib, and the majority are also taking immunomodulatory drugs. Real-world data on usage of the tyrosine kinase inhibitor nintedanib (Ofev ...

Using new technology effectively can boost productivity and reinforce the value of diverse hiring practices.

Online or offline, it does not matter where you find love. Your relationship will succeed if it will. And although there are success stories here and there, the predisposition towards meeting ...